Cargando…

Metabolomics in the Identification of Biomarkers of Asthma

Detalles Bibliográficos
Autores principales:	Villaseñor, Alma, Eguiluz-Gracia, Ibon, Moreira, André, Wheelock, Craig E., Escribese, María M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227545/ https://www.ncbi.nlm.nih.gov/pubmed/34072459 http://dx.doi.org/10.3390/metabo11060346

Ejemplares similares

Metabolomics strategies to discover new biomarkers associated to severe allergic phenotypes
por: Barber, Domingo, et al.
Publicado: (2019)

Omics technologies in allergy and asthma research: An EAACI position paper
por: Radzikowska, Urszula, et al.
Publicado: (2022)

The Utility of Nasal Challenges to Phenotype Asthma Patients
por: Bentabol-Ramos, Guillermo, et al.
Publicado: (2022)

Development of a Novel Targeted Metabolomic LC-QqQ-MS Method in Allergic Inflammation
por: Obeso, David, et al.
Publicado: (2022)

PTGDR2 Expression in Peripheral Blood as a Potential Biomarker in Adult Patients with Asthma
por: García-Sánchez, Asunción, et al.
Publicado: (2021)

A mutually beneficial collaboration between the European Academy of Allergy and Clinical Immunology Junior Members and Clinical and Translational Allergy
por: Tomazic, Peter Valentin, et al.
Publicado: (2016)

Precision Medicine in House Dust Mite-Driven Allergic Asthma
por: Eguiluz-Gracia, Ibon, et al.
Publicado: (2020)

Contribution of allergy in the acquisition of uncontrolled severe asthma
por: Delgado Dolset, María Isabel, et al.
Publicado: (2022)

Comparative metabolomics analysis of bronchial epithelium during barrier establishment after allergen exposure
por: López‐Rodríguez, Juan Carlos, et al.
Publicado: (2021)

Metabolomics analysis identifies different metabotypes of asthma severity
por: Reinke, Stacey N., et al.
Publicado: (2017)

ERS Early Career Members meet EAACI Junior Members: the launch of a strong, fruitful collaboration
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Troubleshooting in Large-Scale LC-ToF-MS Metabolomics Analysis: Solving Complex Issues in Big Cohorts
por: Rodríguez-Coira, Juan, et al.
Publicado: (2019)

Diagnostic Tools in Allergic Rhinitis
por: Testera-Montes, Almudena, et al.
Publicado: (2021)

Experimentally-induced early recruitment of CD14+ monocytes in human allergic rhinitis
por: Eguiluz-Gracia, Ibon, et al.
Publicado: (2014)

How to Diagnose and Treat Local Allergic Rhinitis: A Challenge for Clinicians
por: Eguiluz-Gracia, Ibon, et al.
Publicado: (2019)

Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018)

Understanding Platelets in Infectious and Allergic Lung Diseases
por: Gomez-Casado, Cristina, et al.
Publicado: (2019)

Editorial: Systems Biology Approach to the Immunology of Asthma and Allergy
por: Karaaslan, Cagatay, et al.
Publicado: (2022)

Local Respiratory Allergy: From Rhinitis Phenotype to Disease Spectrum
por: Testera-Montes, Almudena, et al.
Publicado: (2021)

Metabolomics in pulmonary medicine: extracting the most from your data
por: Reinke, Stacey N., et al.
Publicado: (2022)

High-Precision Automated Workflow for Urinary Untargeted Metabolomic Epidemiology
por: Meister, Isabel, et al.
Publicado: (2021)

Emerging Complexity in the Biomarkers of Exacerbation-Prone Asthma
por: Sterk, Peter J., et al.
Publicado: (2020)

Blood molecular biomarkers of the inflammatory phenotypes of asthma
por: Kim, Sae-Hoon
Publicado: (2020)

Olfactomedin 4 as a circulating biomarker for asthma
por: Jang, An-Soo
Publicado: (2022)

Discovering Biomarkers of Neutrophilic Asthma: A Clinician’s Perspective
por: Kang, Noeul, et al.
Publicado: (2021)

Sphingosine-1-Phosphate: Biomarker, Contributor, or Target for Asthma?
por: Kim, Seung-Hyun
Publicado: (2019)

Biomarker development in asthma from a patient's perspective
por: Hamerlijnck, Dominique
Publicado: (2019)

Reply to Thomson: Exposure to Active and Passive Tobacco Smoke on Urinary Eicosanoid Metabolites in Type 2 Asthma
por: Kolmert, Johan, et al.
Publicado: (2021)

Metabolomics in the identification of biomarkers of dietary intake
por: O'Gorman, Aoife, et al.
Publicado: (2013)

Identification of Biomarkers for Preeclampsia Based on Metabolomics
por: Yao, Mengxin, et al.
Publicado: (2022)

Mast Cell Desensitization in Allergen Immunotherapy
por: López-Sanz, Celia, et al.
Publicado: (2022)

Mesenchymal stem cells: an early yet promising prospect for Asthma
por: Villarreal, Mariela, et al.
Publicado: (2022)

Claudin may be a Potential Biomarker for Epithelial Barrier Dysfunction in Asthma
por: Jin, Hyun Jung, et al.
Publicado: (2018)

Oral Microbiota and Pediatric Asthma Phenotype: A New Window for Biomarkers?
por: Ghedin, Elodie, et al.
Publicado: (2023)

Exploring novel systemic biomarker approaches in grass‐pollen sublingual immunotherapy using omics
por: Barker‐Tejeda, Tomas Clive, et al.
Publicado: (2020)

Metabolomic Profiling for Identification of Novel Potential Biomarkers in Cardiovascular Diseases
por: Barderas, Maria G., et al.
Publicado: (2011)

MicroRNAs as Biomarkers in Corticosteroid-Resistant/Neutrophilic Asthma: Still a Long Way to Go!
por: Ricciardolo, Fabio L. M., et al.
Publicado: (2020)

Metabolomic Biomarker Identification in Presence of Outliers and Missing Values
por: Kumar, Nishith, et al.
Publicado: (2017)

Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergetics
por: Smith, Alan M., et al.
Publicado: (2023)

Eosinophil Extracellular Traps Pave the Way for the Identification of Novel Therapeutics in Severe Asthma
por: Lee, Ji-Hyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b14eo2469ct3l01fqsa8jtv8or